Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to investigate the Visual Analog Score (VAS) for pain within the post-operative setting and determine if there is a statistically significant difference between the VAS for PO or IV acetaminophen. It is expected that in doing so the investigators can produce the maximal amount of pain relief after surgery while making conscientious monetary decisions.


Clinical Trial Description

Functional Endoscopic Sinus Surgery (FESS) is one of the most common Ear Nose and Throat Surgeries done in the United States annually. This procedure can vary from intense to moderate pain and as such it is difficult to properly gauge and treat postoperative pain in these patients. Commonly used in these cases, opioid drugs are given to provide adequate analgesia, however higher opioid usage is observed to cause increased Post-Anesthesia Care Unit (PACU) stays, respiratory complications and Postoperative Nausea and Vomiting (PONV). Acetaminophen is commonly used as an adjunct in these circumstances because of its opioid sparing properties.

Acetaminophen is a synthetic nonopioid p-aminophenol derivative available over the counter. Its properties include analgesic and antipyretic qualities and it is listed on the world health organization's list of essential medicines. The potential risks include liver damage, skin reactions and drug interactions when used with blood thinners at high doses. Acetaminophen has been extensively researched, in vitro and in vivo studies have found the drug to be safe when used at proper doses. Recently intravenous use of acetaminophen has gained popularity due to ease of use and ability to be given intraoperatively. This form of acetaminophen, although convenient, is around sixty two times the cost of oral acetaminophen. Due to this increased cost it is imperative that the investigators compare the two routes of administration in order to determine if the additional cost is justified. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03295214
Study type Interventional
Source Massachusetts Eye and Ear Infirmary
Contact Amy Quinkert, PhD
Phone 6175734192
Email amy_quinkert@meei.harvard.edu
Status Recruiting
Phase Phase 3
Start date March 28, 2018
Completion date March 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05564819 - Efficacy and Safety of Acetaminophen in Postoperative Pain Management of Infants Phase 1
Recruiting NCT05517668 - Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose Phase 2
Recruiting NCT06061575 - Comparison of the Efficacy of Paracetamol and Ibuprofen in the Management of Fever in Sepsis Patients Phase 4
Active, not recruiting NCT04459117 - Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen Phase 2/Phase 3
Completed NCT02839876 - Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty Phase 4
Recruiting NCT03763084 - Impact of Acetaminophen on Postoperative Delirium Elderly Patients After Non-cardiac Surgery Early Phase 1
Completed NCT04175509 - Improving Post-Operative Pain and Recovery in Gynecologic Surgery Phase 4
Recruiting NCT04964310 - Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study
Recruiting NCT04290208 - A Comparison of IV Versus PO Acetaminophen Postoperatively for Opioid Consumption After Cesarean Section Phase 4
Enrolling by invitation NCT06275191 - Alternatives to Dental Opioid Prescribing After Tooth Extraction N/A